Altimmune, Inc.
ALT
$7.03
$0.253.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.55% | -1.47% | 7.28% | -1.01% | 22.90% |
| Total Depreciation and Amortization | -12.12% | -10.81% | -39.34% | -42.99% | -6.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.06% | 15.86% | -37.04% | 23.93% | -81.13% |
| Change in Net Operating Assets | -124.68% | 138.52% | -302.69% | -39.94% | 540.07% |
| Cash from Operations | 7.80% | 32.65% | -49.76% | -10.70% | 1.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -137.42% | 1,036.95% | 132.44% | 90.65% | -396.56% |
| Cash from Investing | -137.42% | 1,036.95% | 132.44% | 90.65% | -396.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 246.21% | 3,635.93% | 36.36% | -41.59% | -99.53% |
| Repurchase of Common Stock | -33,800.00% | 50.00% | 98.36% | 59.33% | -1,521.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 238.31% | 3,691.35% | 678.26% | 82.38% | -100.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.37% | 121.25% | -17.41% | 61.08% | -216.32% |